The Dystrophy Annihilation Research Trust

The Dystrophy Annihilation Research Trust (DART) is a premier Indian non-profit biotechnology organization focused on developing indigenous and affordable therapies for Duchenne Muscular Dystrophy (DMD). Founded by parents of a child with DMD, the trust operates a specialized research laboratory in Bangalore dedicated to genetic medicine. DART's primary technological focus is the development of antisense oligonucleotides (ASOs) designed for exon skipping to restore dystrophin protein production. The organization has successfully transitioned its lead ASO candidates into clinical trials, marking a significant milestone for rare disease research in India. By collaborating with academic institutions and government bodies, DART aims to bridge the gap between laboratory research and clinical application for neuromuscular disorders.